These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 37059912)

  • 1. Advanced Formulation Approaches for Proteins.
    Schlosser CS; Williams GR; Dziemidowicz K
    Handb Exp Pharmacol; 2024; 284():69-91. PubMed ID: 37059912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Particle engineering principles and technologies for pharmaceutical biologics.
    Cun D; Zhang C; Bera H; Yang M
    Adv Drug Deliv Rev; 2021 Jul; 174():140-167. PubMed ID: 33845039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced formulations for intranasal delivery of biologics.
    Rohrer J; Lupo N; Bernkop-Schnürch A
    Int J Pharm; 2018 Dec; 553(1-2):8-20. PubMed ID: 30316796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Just how prevalent are peptide therapeutic products? A critical review.
    Zhang Y; Zhang H; Ghosh D; Williams RO
    Int J Pharm; 2020 Sep; 587():119491. PubMed ID: 32622810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lyophilized liposome-based parenteral drug development: Reviewing complex product design strategies and current regulatory environments.
    Wang Y; Grainger DW
    Adv Drug Deliv Rev; 2019; 151-152():56-71. PubMed ID: 30898571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular delivery of proteins and peptides: Challenges and novel formulation approaches.
    Mandal A; Pal D; Agrahari V; Trinh HM; Joseph M; Mitra AK
    Adv Drug Deliv Rev; 2018 Feb; 126():67-95. PubMed ID: 29339145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MAbDelivery: Administration routes for antibody therapy Third LabEx MAbImprove industrial workshop, July 2, 2015 Tours, France.
    Bodier-Montagutelli E; Respaud R; Watier H; Guillon-Munos A
    MAbs; 2017; 9(4):579-585. PubMed ID: 28346048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel delivery technologies for protein and peptide therapeutics.
    Kumar TR; Soppimath K; Nachaegari SK
    Curr Pharm Biotechnol; 2006 Aug; 7(4):261-76. PubMed ID: 16918403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for overcoming protein and peptide instability in biodegradable drug delivery systems.
    Shi M; McHugh KJ
    Adv Drug Deliv Rev; 2023 Aug; 199():114904. PubMed ID: 37263542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term delivery of protein therapeutics.
    Vaishya R; Khurana V; Patel S; Mitra AK
    Expert Opin Drug Deliv; 2015 Mar; 12(3):415-40. PubMed ID: 25251334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein drug oral delivery: the recent progress.
    Lee HJ
    Arch Pharm Res; 2002 Oct; 25(5):572-84. PubMed ID: 12433186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Narrative Review on Non-Invasive Drug Delivery of Teriparatide: A Ray of Hope.
    Mittal N; Sharma G; Katare OP; Bhadada SK
    Crit Rev Ther Drug Carrier Syst; 2023; 40(6):117-140. PubMed ID: 37585311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced Formulation Approaches for Emerging Therapeutic Technologies.
    Allahham N; Colic I; Rayner MLD; Gurnani P; Phillips JB; Rahim AA; Williams GR
    Handb Exp Pharmacol; 2024; 284():343-365. PubMed ID: 37733107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules.
    Choonara BF; Choonara YE; Kumar P; Bijukumar D; du Toit LC; Pillay V
    Biotechnol Adv; 2014 Nov; 32(7):1269-1282. PubMed ID: 25099657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dry powder pharmaceutical biologics for inhalation therapy.
    Chang RYK; Chow MYT; Khanal D; Chen D; Chan HK
    Adv Drug Deliv Rev; 2021 May; 172():64-79. PubMed ID: 33705876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic delivery of peptides by the oral route: Formulation and medicinal chemistry approaches.
    Brayden DJ; Hill TA; Fairlie DP; Maher S; Mrsny RJ
    Adv Drug Deliv Rev; 2020; 157():2-36. PubMed ID: 32479930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous Delivery of High-Dose/Volume Biologics: Current Status and Prospect for Future Advancements.
    Badkar AV; Gandhi RB; Davis SP; LaBarre MJ
    Drug Des Devel Ther; 2021; 15():159-170. PubMed ID: 33469268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral Delivery of Therapeutic Proteins and Peptides: An Overview of Current Technologies and Recommendations for Bridging from Approved Intravenous or Subcutaneous Administration to Novel Oral Regimens.
    Philippart M; Schmidt J; Bittner B
    Drug Res (Stuttg); 2016 Mar; 66(3):113-20. PubMed ID: 26536331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging delivery platforms for mucosal administration of biopharmaceuticals: a critical update on nasal, pulmonary and oral routes.
    Thwala LN; Préat V; Csaba NS
    Expert Opin Drug Deliv; 2017 Jan; 14(1):23-36. PubMed ID: 27351299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.